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Pelvic actinomycosis comprises a rare, subacute to chronic bacterial infection characterised by suppurative and
granulomatous inflammation. Diagnosis is difficult as it may simulate pelvic malignancies. Laboratory and radiological
findings are non-specific. We reported on 2 cases of pelvic actinomycosis mimicking ovarian malignancy with different
management approaches that lead to opposite outcomes. We reviewed the literature on pelvic actinomycosis imitating
ovarian cancer with a focus on its surgical management. Despite agreement on the duration of antibiotic therapy
following surgical management, consensus regarding surgical approach was rather equivocal. We concluded that
pelvic actinomycosis should be strongly suspected in women with presumed ovarian cancer of atypical presentation
and a history of intrauterine devices (IUD).Background
Actinomycosis comprises a subacute to chronic bacterial
infection caused by filamentous, gram-positive, nonacid-
fast, anaerobic bacteria. It is characterised by contiguous,
suppurative and granulomatous inflammation. Pelvic acti-
nomycosis although rare, occurs almost only in women.
It may simulate pelvic malignancies or retroperitoneal
tumours [1], which often makes it difficult to diagnose.
Pelvic organs can be affected leading to different clinical
presentations. A high index of disease suspicion in pa-
tients with a history of intrauterine devices (IUD) can
prevent unnecessary extensive surgical procedures [2].
Radiological findings are non-specific, however com-
puted tomography (CT) appears to be the most useful
imaging modality. We presented 2 case reports of pelvic
actinomycosis with different management approaches
that lead to opposite outcomes. We also conducted a lit-
erature review to add on the understanding of this rare
disease.* Correspondence: alex.laios@obs-gyn.ox.ac.uk
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Case report 1
A 57-year old, mother of two, postmenopausal caucasian
woman was referred to our centre following MDT discus-
sion for a 4-month long, persistent, progressively worsen-
ing lower abdominal pain. This was associated with mild,
offensive vaginal discharge but no vaginal bleeding. She
had a significant weight loss (19 kg over 1 month), loss
of appetite, dysuria and constipation. Her past medical
history included bipolar disorder, hypothyroidism and
hypertension. She had a recent psychotic episode fol-
lowing discontinuation of her medication due to lithium
toxicity. She had no previous abdominal or pelvic sur-
geries, abdominal wall trauma or immunosuppression.
The patient was previously on HRT for 8 years and had
a copper IUD in situ for the last 9 years. Her family his-
tory was unremarkable.
Physical examination demonstrated a large abdominal
mass protruding through the anterior abdominal wall
between the umbilicus and symphysis pubis. She was
afebrile and had mild generalised abdominal tenderness
but no rigidity or guarding. Pelvic examination revealed
a 20-week sized gravid uterus and a fixed solid abdomino-
pelvic mass with no cervical motion tenderness. Laboratory
investigations demonstrated mild anaemia (Hb: 9 g/dL),
raised CRP at 118 mg/l and leucocytosis (WCC 27 × 103/μl).d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cystic pelvic masses, inseparable from each other. This
was confirmed by CT, which additionally reported a soft
anterior abdominal wall mass 60 × 25 × 60 mm situated
below the umbilicus involving the right rectus abdominis
muscle. A small amount of fluid in the right paracolic
gutter was seen in addition to generalised peritoneal dis-
ease and sigmoid involvement. The overall picture was
suggestive of malignant ovarian disease (Figure 1a-b).
CA125 was 39 U/ml, CEA and CA199 were normal.
The patient was transfused preoperatively due to low
haemoglobin and scheduled for an exploratory laparotomy
preceded by laparoscopy. Unfortunately, due to deterior-
ation of her symptoms, she underwent an emergency pro-
cedure. Following initial laparoscopic assessment to assess
the disease operability, she underwent an en bloc pelvic
resection with total abdominal hysterectomy and bilateral
salpingo-ophorectomy, omentectomy, bladder peritonect-
omy, rectosigmoid resection with re-anastomosis and exci-
sion of an anterior abdominal wall tumour. Subsequently,
she required a defunctioning stoma due to pelvic sepsis and
partial closure of the abdominal defect with a prolene mesh.
Further debridement was required, which was followed
by a split skin graft from her right thigh. Histology re-
vealed widespread abdominal and pelvic actinomycosis
with a florid inflammatory and fibrotic response com-
prising of microabscesses (Figures 1c and 2). A tumour
mass effect was seen (Figure 3). Active chronic inflam-
mation in the endometrial cavity, most likely associated
with the IUD was reported. She remained on IV benzyl-
penicillin 1.8 mg/4 h for a total of 6 weeks. She was dis-
charged at 2 months with a low grade wound infectionFigure 1 Surgical procedures, imaging and pathological findings. Case
bilateral ovarian masses with coil in situ b) coronal view c) colony of Actin
fibrosis which had disrupted the smooth muscle of bowel wall rendering a
computed tomography (CT) scan showing right complex adnexal mas
mass with IUD in situ (coronal) f) colony of Actinomyces surrounded
image, there is fibrosis (H&E stain, 10×).secondary to foreign mesh material reaction and a rather
erratic colostomy performance required supportive man-
agement. She became systemically well. Oral amoxicillin
500 mg 3 times daily was initially considered until reversal
of the colostomy. At 9 months follow-up, endoscopy
showed mild active proctitis and as it deemed unsafe to
restore GI continuity, a revision of her end colostomy with
reconstruction of abdominal wall was undertaken. The
total duration of oral antibiotics was 12 months.Case report 2
A 37-year old, mother of two, caucasian woman was ini-
tially presented to the gastroenterology team for investiga-
tion of a 3-month long persistent, progressively worsening
lower abdominal pain. This was severe in nature, pre-
dominant in the left flank, lasting for a few seconds and
spontaneously resolving. It was associated with significant
weight loss (15 kg over 2 months), pyrexia, night sweats,
anorexia and altered bowel habits. Her medical history in-
cluded asthma. She had no previous abdominal surgery,
trauma or immunosuppression. She had a copper IUD in
situ for 4 years. There was a family history of colon cancer
and Crohn’s disease.
On physical examination, there was no pyrexia. There
was left flank and iliac fossa tenderness with no rigidity
or guarding and mild left lower limb oedema. Pelvic
examination revealed a tender, solid, fixed pelvic mass
extending to the left pelvic side wall and the posterior
sacral region. Doppler ultrasonography (US) of the left
lower limb ruled out deep vein thrombosis and superficial
thrombophlebitis. Laboratory investigations demonstrated1 - a) Axial preoperative abdominopelvic CT scan showing inseparable
omyces organisms surrounded by inflammatory cells with adjacent
‘mass’ (H&E stain, 10×). Case 2 - d) preoperative abdominopelvic
s (axial) e) preoperative abdominopelvic CT showing presacral
by acute and chronic inflammatory cells. To the right of the
Figure 2 Colony of Actinomyces organisms (Grocott stain, 40×).
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cytosis (WCC 14.3 × 103/μl).
Gastro-duodenoscopy revealed mild chronic gastritis
and reactive gastropathy whilst colonoscopy ruled out
the possibility of inflammatory bowel disease. CT thorax-
abdomen-pelvis scan revealed a 75 × 61 mm complex
right adnexal mass and a 52 × 41 mm heterogeneous pre-
sacral mass. Multiple smaller masses were seen in the left
flank, left iliac fossa and anterior pelvis, consistent with
metastatic disease (Figure 1d-e). Several loops of small
bowel appeared to be tethered in the pelvis and were par-
tially obstructed. The rectum was thought to be infiltrated
by the pre-sacral mass. There were bilateral hydro-
nephroses. There was small volume of ascites with some
associated peritoneal enhancement and mild left pleural
effusion with no evidence of lung parenchymal metastases.
The case was discussed at the gynaecologic oncology
multidisciplinary team (MDT) due to high suspicion ofFigure 3 Mass effect. Another area in the exenteration sample in
case 1 showing the inflammation and fibrosis which has caused a
mass effect (H&E stain, 10×).advanced ovarian cancer. Tumour markers included ele-
vated CA125 at 83 U/ml, CA199 at 51 U/ml; AFP and
CEA were normal. A US-guided percutaneous biopsy of
the left adnexal mass was performed as per MDT deci-
sion, which was abandoned as there was no safe path
to the lesion and hence diagnostic laparoscopy and biop-
sies were planned instead.
At laparoscopy, there were multiple omental and large
bowel adhesions to the anterior and lateral abdominal
wall. The right adnexal mass was not visualised as the
adjacent small bowel was obscuring the right ovary. A
left pelvic side wall biopsy was taken and ascitic fluid
was drained. Histology confirmed a benign peritoneal
nodule showing fibrosing inflammation in association
with actinomyces colonies. The latter were surrounded
by acute suppurative exudate within chronic inflammation
and prominent foamy macrophages (Figure 1f). The fi-
brous band rendered a mass effect. No dysplasia or malig-
nancy was present. Cytology was negative for malignancy
too. This was therefore a case of severe pelvic inflamma-
tory disease secondary to actinomyces infection. The pa-
tient made an uneventful recovery. She had a negative
STD work-up and the IUD was removed. However, IUD
culture failed to isolate actinomyces. Blood cultures were
negative for bacteraemia. She was advised against reinser-
tion of the IUD.
The patient was commenced on intravenous (IV) ben-
zylpenicilline 1.8 mg 4-hourly followed by IV ceftriaxone
2 g daily for 6 weeks. She was then switched to oral
amoxicillin 500 mg 3 times daily totalling 6 months. As
a result, her weight increased steadily whilst her night
sweats and abdominal discomfort subsided. All haemato-
logical parameters returned to normal. Abdominopelvic
examination prior to discharge was unremarkable. She
returned to follow-up appointments at 6 weeks and
6 months and was completely asymptomatic.
Literature review
We searched the MEDLINE and EMBASE databases for
articles published between 1988 and 2013 using medical
subject heading (MeSH) terms. Key terms included “pelvic
actinomycosis” and “ovar* cancer or tumour or carcinoma
or neoplasm”. The search was limited to the words
“humans and adult female”. Additional publications were
identified via cross-referencing from reference lists within
the retrieved publications. Only case series published in
English language but with no geographical restrictions
were included in the literature review.
Results
The electronic search initially yielded 36 citations. Eleven
reports were published in language other than english.
There were two duplicate studies. Five studies were un-
related after screening titles; one study was a review, 3
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and tubo-ovarian abscesses respectively and one study
was on a pediatric patient. In 2 studies, abstracts were
not available and they were further excluded. A total of
16 publications were finally included in the literature re-
view (Figure 4). The main characteristics of those case
report studies with an emphasis to their management
are shown in Table 1.
Discussion
Our institution is a tertiary referral cancer centre; as
large numbers of patients are referred with presumed
metastatic ovarian or primary peritoneal cancer, it is im-
portant to determine the frequency and nature of dis-
eases that mimic malignancy. In this context, pelvic
actinomycosis, although difficult to diagnose by virtue of
its rarity [18], should be included in the differential diag-
nosis of ovarian cancer, especially if atypical presentation
occurs.
We reported 2 cases of women who were diagnosed
with extensive pelvic actinomycosis following surgical
intervention. All management decisions were MDT ap-
proved and documented in MDT proformas. Their differ-
ent management demonstrates the importance of making
the diagnosis in an evocative clinical context, performing
the necessary investigations to confirm suspicions, favour-
ing medical treatment and possibly reserving surgical treat-
ment for specific situations (Figure 5).
Both patients had a long standing history of copper
IUD use. Pelvic actinomycosis accompanied by IUD ac-
counts for about 3% of all actinomycosis [19]. AlthoughFigure 4 Comprehensive review selection strategy.uncommon, a long duration of IUD appears to confer
the greatest risk [1]. Signs of infection such as fever,
night sweats and leucocytosis also add suspicion towards
an infective cause or accurately predict the severity of
the condition [20]. In our cases, abdominopelvic pain as-
sociated with significant weight loss constituted the prom-
inent symptoms. As ovarian malignancy was presumed in
both cases, staging CT scans were included in the diagnos-
tic work-up. CT findings although useful in the preopera-
tive diagnosis were non-specific to differentiate between
malignancy and actinomycocis. They are quite often, simi-
lar to those in Crohn’s disease or intestinal tuberculosis.
However, they might show the aggressive, infiltrative na-
ture of the disease with disruption of tissue planes and
demonstrate one or more solid masses with thickened
walls [21]. The first patient was initially referred from a re-
gional hospital for MDT discussion. In the light of sus-
pected advanced ovarian cancer and while waiting for an
elective procedure with the intention-to-treat, she deterio-
rated and transferred to our centre. She underwent an
emergency laparoscopy proceeding to exploratory laparot-
omy with en bloc resection. In the absence of emergency,
a more conservative surgical approach should have been
pursued. Performing such an extensive operation in such
an infected surgical field added to the complications en-
countered in the postoperative period. The learning ex-
perience from that first case was reflected on the MDT
discussion of the second case, yet ovarian malignant dis-
ease was the working diagnosis. A biopsy taken at the time
of a diagnostic laparoscopy confirmed actinomycosis in-
fection [22]. Frozen section should be considered in cases
Table 1 Case report studies on pelvic actinomycosis mimicking advanced ovarian cancer
Case report studies on pelvic actinomycosis mimicking advanced ovarian cancer
Reference Age
(years)




Gungor T et al. [3],
2013 (n = 1)
43 Pelvic actinomycosis: a disease that should
not be overlooked in cases with suspected
ovarian cancer
7 Explorative laparotomy and debulking
surgery
Kim YS et al. [4],
2012 (n = 1)
41 Metastatic hepatic actinomycosis
masquerading as distant metastases of
ovarian cancer
15 Hepatic actinomycosis misdiagnosed as
distant metastases of ovarian cancer,
exploratory laparotomy with frozen section
of pelvic mass, penicillin totalling 5 months
Ong C et al. [5],
2012 (n = 1)
73 Actinomyces turicensis infection mimicking
ovarian tumour
No IUD Pelvic mass and enlarged supraclavicular LN,
non-diagnostic FNA, blood cultures positive
for actinomyces, penicillin totalling 7 months
Pusiol T et al. [2],
2011 (n = 1)
46 Abdomino-pelvic actinomycosis mimicking
malignant neoplasm
3 Uncomplicated explorative laparotomy and
debulking surgery but incomplete staging,
penicillin totalling 6 months
Hwang JH et al. [6],
2010 (n = 1)
59 Primary serous papillary carcinoma of the
peritoneum mimicking pelvic actinomycosis:
a case report and brief literature review
No IUD Pelvic CT and MRI suggestive of pelvic
actinomycosis. Full staging debulking surgery
confirmed primary peritoneal carcinoma
followed by adjuvant chemotherapy
Kumar N et al. [7],
2010 (n = 1)
32 Pelvic actinomycosis mimicking an advanced
ovarian cancer
2 IUD removed 4 months prior to admission,
uncomplicated explorative laparotomy and
debulking surgery, incomplete staging
Lee YK et al. [8],
2008 (n = 1)
42 Pelvic actinomycosis with hydronephrosis
and colon stricture simulating an advanced
ovarian cancer
8 Imaging guided needle biopsy made correct
nonsurgical diagnosis, antibiotic treatment,
no surgery required
Akhan SE et al. [9],
2008 (n = 3)
38, 37, 51 Pelvic actinomycosis mimicking ovarian
malignancy: three cases
>7 Debulking surgeries in all cases, complete/
incomplete staging, second case was
complicated by need for colostomy and
fascial necrosis
Kim HS et al. [10],
2007 (n = 1)
47 A case of pelvic actinomycosis with hepatic
actinomycotic pseudotumor
18 FNA of hepatic tumour and explorative
laparotomy of pelvis masses followed by
penicillin totalling 4 months
Sehouli J et al. [11],
2006 (n = 1)
35 Actinomycotic inflammatory disease and
misdiagnosis of ovarian cancer
10 Ureteric stenting followed by uncomplicated
explorative laparotomy, patient received
ampicillin and sulbactam totalling 6 weeks
Atay Y et al. [12],
2005 (n = 3)
37, 45, 47 Ovarian actinomycosis mimicking
malignancy
No IUD Explorative laparotomy and intraoperative
frozen section diagnosis of actinomycosis,
long-term penicillin totalling 3 months
Oztekin K et al. [13],
2004 (n = 1)
49 Pelvic actinomycosis in a postmenopausal
patient with systemic lupus erythematosus
mimicking ovarian malignancy; case report
and review of literature
No IUD Rare occurrence of actinomycosis with an
autoimmune disease that predisposed to
infections, patient had laparotomy
Koshiyama M et al. [14],
1999 (n = 1)
52 Ovarian actinomycosis complicated by
diabetes mellitus simulating an advanced
ovarian carcinoma
No IUD MRI detected solid pelvic tumour mimicking
advanced ovarian carcinoma invasive to
bladder, rectum and uterus, patient denied
initial explorative laparotomy, had
neodjuvant chemotherapy followed by
incomplete staging laparotomy and long-
term penicillin, colostomy secondary to rec-
tovaginal fistula
Hawnaur JM et al. [15],
1999 (n = 1)
43 Magnetic resonance imaging of actinomycosis
presenting as pelvic malignancy
10 MRI confirmed regression of pelvic disease
in response to antibiotic therapy
Kirova YM et al. [16],
1997 (n = 1)
37 IUD-associated pelvic actinomycosis: a rare
disease mimicking advanced ovarian cancer; a
case report
4 CT detected pelvic mass with liver
metastases mimicking advanced ovarian
carcinoma, exploratory laparotomy and
debulking surgery, incomplete staging
Hoffman MS et al., [17],
1991 (n = 2)
N/A Advanced actinomycotic pelvic inflammatory
disease simulating gynecologic malignancy. A
report of two cases.
Plastic IUCD, 7, 17 Laparotomy and long-term penicillin, some
resolution of the pelvic fibrosis
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Figure 5 Differentiation between the two reported cases with pelvic actinomycosis.
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surgery [23]. Recently, a high detection rate of actino-
myces by cytology has been suggested adding on the
diagnosis [24].
Several case reports of pelvic actinomycosis mimicking
ovarian malignancies have been published [3,25-27] and
(Table 1). Pelvic actinomycosis has been known to present
as a rectal mass with hydronephrosis [28], following hys-
teroscopic removal of IUD [29] or incarcerated inguinal
hernia [30]. In the presence of an abdominopelvic mass
with suspected deposits, laparoscopy was a less invasive
approach of establishing a definitive diagnosis, thereby
minimising the risk for mutilating surgery. In most re-
ports pelvic actinomycosis was diagnosed in women
younger than 50 years old, who would not benefit from
extensive surgery, especially as medical treatment was
likely to be successful. Adjuvant debulking surgery
could have taken place later if medical treatment was
unsuccessful or if the patient developed complications
[31]. Nonetheless, Nagler suggested that patients may
not respond well to antibiotics before lesion resec-
tion, possibly due to compartmentalisation of organisms
within granulation tissue [32]. Aggressive surgical man-
agement including extensive surgery –full debulking- is
overwhelmingly supported in the literature [3,9,11,14,33,34]
taking into consideration the extent of the disease and
patient’s condition (Table 1). Alternatively, incomplete
staging may be offered [2,7,16,17] as an intermediate
approach with lower morbidity risk while histology is
pending.
According to this review, there was no consensus with re-
spect to surgical management of actinomycosis. Agreementcame only with the approximate duration of antibiotic
treatment. Once diagnosis was made, high-dose and long-
term use of penicillin was recommended to eradicate acti-
nomycosis. IV benzylpenicillin was administered daily for
up to 6 weeks following surgery. Oral treatment should be
continued for a period of at least 6 months due to low
penetration in the fibrosis and the tendency to recur [4].
Conclusion
Despite advanced imaging and diagnostics, it is important to
suspect actinomycosis in women who present with a pre-
sumed ovarian cancer and a history of IUD. This will spare
patients from unnecessary, potentially extensive surgery.
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